Affymetrix (Santa Clara, California) Launches Industry’s Broadest-Selection Of Standard And Custom SNP Panels For Targeted Genotyping Applications

SANTA CLARA, Calif.--(BUSINESS WIRE)--Dec. 19, 2005--Affymetrix Inc. (Nasdaq:AFFX) today launched the industry’s broadest-selection of standard and custom SNP panels for targeted genotyping applications. The new selection includes custom panels spanning 1,500 to 20,000 SNPs per assay, as well as seven standard SNP panels for whole-genome coding SNP analysis, disease-related studies and common animal research.

MORE ON THIS TOPIC